A peer-reviewed study in the highly regarded journal The Lancet found that Sputnik V, a new COVID-19 vaccine developed in Russia, was 91.6% effective in preventing infection with the novel coronavirus. The study included 22,000 subjects and…

The United States Department of Defense has entered into a $231 million agreement with the Australian company, Ellume, to fund the manufacture of its rapid and inexpensive COVID-19 test. Available without a prescription, the COVID-19 test…

According to researchers in the United Kingdom, changes to the tongue’s appearance—including discoloration and enlargement—may be symptomatic of COVID-19. While traditional COVID-19 symptoms, such as fever, cough, and loss of taste and…

To increase the number of vaccine providers throughout the state, California’s Department of Public Health has decreased the training requirements necessary for dentists to administer COVID-19 vaccines. Now, dentists must complete one…

Results from Phase 3 clinical trials on Johnson & Johnson’s (J&J) one-dose COVID-19 vaccine demonstrated 72% effectiveness against moderate to severe COVID-19-related illness in the United States. However, this rate dropped to 57%…

A new variant to the novel coronavirus—referred to as P.1—emerged in December in Manaus, Brazil. Its high level of infectivity led to a steep rise in COVID-19 cases in the area. Public health officials are concerned due to P.1’s ability to…

The number of new COVID-19 cases is decreasing across the United States, while the number of patients hospitalized due to COVID-19 illness is at the lowest level since mid-December. More than 30 states have experienced declines in new case…

As new, more infectious variants to the novel coronavirus spread across the world, Pfizer, in collaboration with its partner BioNTech, is developing a booster shot that would offer protection against new strains that may evolve. The company…

Two vaccines developed to prevent infection with the novel coronavirus have been abandoned due to poor performance in clinical trials. Manufactured by Durham, North Carolina-based Merck in partnership with the nonprofit organization IAVI,…

Unfortunately, many Americans—especially older adults—are unsure of how to receive the COVID-19 vaccinations. In fact, according to the Kaiser Family Foundation, six out of 10 older Americans don’t know if they are eligible or how to get…